Hank F Kung Selected Research

azomycin

5/2011

Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hank F Kung Research Topics

Disease

43	Neoplasms (Cancer) 03/2024 - 09/2004
38	Alzheimer Disease (Alzheimer's Disease) 07/2021 - 08/2002
16	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 02/2006
13	Amyloid Plaque 01/2021 - 01/2003
11	Parkinson Disease (Parkinson's Disease) 09/2019 - 01/2003
7	Neoplasm Metastasis (Metastasis) 03/2024 - 11/2018
5	Glioma (Gliomas) 01/2018 - 08/2011
4	Dementia (Dementias) 01/2021 - 01/2011
4	Breast Neoplasms (Breast Cancer) 01/2018 - 02/2006
2	Insulinoma 12/2022 - 11/2021
2	Lymphoma (Lymphomas) 01/2021 - 01/2018
2	Hypoxia (Hypoxemia) 01/2019 - 05/2011
2	Brain Diseases (Brain Disorder) 01/2018 - 11/2013
2	Cognitive Dysfunction 01/2012 - 06/2010
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2010 - 02/2008
2	Scrapie 12/2010 - 02/2008
2	Diabetes Mellitus 11/2008 - 07/2008
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2006 - 01/2003
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 08/2002 - 06/2002
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2024
1	Lymphatic Metastasis 04/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	Adenocarcinoma 10/2022
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021
1	Lobular Carcinoma 01/2018
1	Disease Progression 04/2017
1	Triple Negative Breast Neoplasms 01/2017
1	Parkinsonian Disorders (Parkinsonism) 06/2014

Drug/Important Bio-Agent (IBA)

17	Glutamine (L-Glutamine)FDA Link 01/2019 - 02/2011
16	Amyloid beta-PeptidesIBA 06/2010 - 08/2002
13	LigandsIBA 01/2023 - 02/2003
12	Amyloid (Amyloid Fibrils)IBA 01/2021 - 05/2005
11	AntigensIBA 04/2024 - 01/2018
8	florbetapirIBA 07/2021 - 06/2010
7	Radioisotopes (Radionuclides)IBA 04/2024 - 05/2011
7	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 09/2019 - 08/2006
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2010
6	2,3-dihydro-1H-imidazo(1,2-b)pyrazole (IMPY)IBA 12/2010 - 01/2003
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 08/2011
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023 - 04/2017
4	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 03/2024 - 01/2018
4	RadiopharmaceuticalsIBA 01/2024 - 01/2003
4	Glutamic Acid (Glutamate)FDA Link 01/2020 - 09/2012
4	dihydrotetrabenazineIBA 05/2019 - 08/2006
4	Amino Acids FDA Link 11/2014 - 01/2011
4	florbenazine F 18IBA 06/2014 - 05/2010
4	StilbenesIBA 02/2010 - 08/2003
3	Diphosphonates (Bisphosphonates)IBA 03/2024 - 01/2016
3	4-fluoroglutamineIBA 01/2021 - 12/2011
3	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2018 - 11/2003
3	Alanine (L-Alanine)FDA Link 01/2018 - 10/2012
3	sigma-2 receptorIBA 12/2010 - 02/2006
3	pyridineIBA 02/2008 - 10/2004
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2003 - 06/2002
2	AlbuminsIBA 04/2024 - 10/2022
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 03/2024 - 01/2023
2	gallium 68 PSMA-11IBA 01/2023 - 10/2022
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 11/2021
2	Fluorine-18IBA 01/2019 - 12/2010
2	NitroimidazolesIBA 01/2019 - 05/2011
2	fluoromisonidazoleIBA 01/2019 - 05/2011
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018 - 01/2014
2	EnzymesIBA 12/2016 - 09/2012
2	Dopamine (Intropin)FDA LinkGeneric 06/2014 - 01/2003
2	AD 20 (AD-20)IBA 01/2012 - 07/2011
2	Polytetrafluoroethylene (Teflon)FDA Link 04/2011 - 01/2011
2	PrionsIBA 12/2010 - 02/2008
2	Peptides (Polypeptides)IBA 11/2009 - 02/2003
2	Insulin (Novolin)FDA Link 11/2008 - 07/2008
2	benzofuranIBA 05/2006 - 08/2002
1	N,N'- bis(2- hydroxybenzyl)ethylenediamine- N,N'- diacetic acid (HBED)IBA 03/2024
1	AlloxanIBA 02/2024
1	5'-deoxy-5'-phosphonomethyladenosine phosphateIBA 01/2024
1	68 Ga-P16-093IBA 04/2023
1	Prostate-Specific Antigen (Semenogelase)IBA 04/2023
1	G(A1) ganglioside (GA(1))IBA 01/2023
1	7- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA 12/2022
1	Exenatide (Byetta)FDA Link 11/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 11/2021
1	methylene diphosphonateIBA 03/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2021
1	flutemetamolIBA 01/2021
1	Technetium Tc 99m MedronateIBA 01/2021
1	2- (3- (1- carboxy- 5- (3- (4- iodobphenyl)ureido)pentyl)ureido)pentanedioic acidIBA 01/2020
1	Amino Acid Transport System LIBA 01/2019
1	EstersIBA 01/2019
1	AcidsIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	FluorineIBA 01/2018
1	Urea (Carbamide)FDA LinkGeneric 01/2018
1	DipeptidesIBA 01/2018
1	GlutaminaseIBA 01/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 06/2014

Therapy/Procedure

9	Therapeutics 04/2024 - 06/2014
2	Intravenous Administration 01/2020 - 06/2014
2	Radiotherapy 01/2020 - 02/2015
1	Castration 04/2024
1	Precision Medicine 03/2024
1	Drug Therapy (Chemotherapy) 10/2019
1	Denervation 06/2014